Press Releases

Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

Chantal van Gils joins NDA Advisory Board as Director of Epidemiology and Real-World Evidence

NDA Group has announced that Chantal van Gils NDA, MD, Ph.D., specialist in epidemiological analyses and outcome research, joins the NDA Advisory Board as Director of Epidemiology and Real-World Evidence.

LIQUID STABLE & MULTI-ANALYTE CLINICAL REFERENCE MATERIALS FOR ELECTROLYTE TESTING AVAILABLE FROM VERICHEM

Shimmer Research Launches the Verisense Digital Health Panel to Create a Universal, Device Independent, Ground Truth Dataset to Accelerate Digital Health

The DHP will systematically collect raw digital health data to facilitate collaboration and accelerate the progress of digital health technologies.

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS

Proscia To Showcase Improvements In Artificial Intelligence Generalization At The Conference On Neural Information Processing Systems

Retrospective study demonstrated 56.3% increase in melanoma detection sensitivity through use of contrastive self-supervised learning

Ion Exchange Resins for Water Purification, Metal Separation, Catalysis, and Column Chromatography

The application fields of ion exchange resins continue to expand, covering water treatment, environmental remediation, hydrometallurgy, chromatography, biomolecular separation, etc.

Celebrating the role of Genetic Counsellors in healthcare

Genomics England, The British Society for Genetic Medicine (BSGM) and the Association of Genetic Nurses and Counsellors, are all joining forces to celebrate the expertise of genetic counsellors on Genetic Counsellor Awareness Day — Thursday 10 November 2022.

Next-generation of qPCR Reagents Push the Boundaries of Performance

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara™ Probe Mix, Clara™ Probe 1-Step Mix and Clara™ HRM Mix.

PathAI to Present on AI Models Supporting Advances in Oncology Research at Society for Immunotherapy of Cancer Annual Meeting

PathAI will share five new posters at SITC 2022, all developed in collaboration with biopharmaceutical partners, that highlight their new AI-model development to support advances in oncology research across several disease areas such as non-small cell lung cancer (NSCLC), cholangiocarcinoma, and urothelial carcinoma.

New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference

A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.

Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place

The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.

Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions

CD ComputaBio Introduces Four Docking Software for Drug Development

Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services

Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service

Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits

Rising Prevalence of Isotope Labeling Carbohydrates Drives Innovations at BOC Sciences

BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.

BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.

BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.